Rachel Yost is an Associate Director, MSAT at GentiBio. Prior to joining GentiBio, Rachel worked at Juno Therapeutics / Bristol Myers Squibb, playing a significant role in Global Manufacturing, Science & Technology (MSAT) throughout the lifecycle of the Breyanzi CAR-T cell therapy product. Most recently Rachel lead the MSAT Early Phase Drug Product Stewardship team supporting multiple pipeline cell therapy programs. Rachel was previously a process engineer at Merck in Durham, NC. Rachel received her BS in Bioengineering from Penn State. Outside of work, Rachel enjoys running, skiing, traveling, and spending time with her husband and their dog.
Rachel Yost, BS
Associate Director, MSAT